Cargando…

IDF21-0294 Impact of COVID-19 pandemic lockdown in Spain on metabolic control of patients with type 2 diabetes mellitus

Detalles Bibliográficos
Autores principales:	Cornadó-Cubells, G., Cabré, J.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164622/ http://dx.doi.org/10.1016/j.diabres.2022.109333

Ejemplares similares

IDF21-0439 Type 2 Diabetes Mellitus History in the Prognosis of Hospitalized COVID-19 Patients – A Prospective Observational Study
por: Kochuparambil, J.J., et al.
Publicado: (2022)

IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19
por: Syukur, C., et al.
Publicado: (2022)

IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic
por: Almutairi, M., et al.
Publicado: (2022)

IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus?
por: Jashi, L., et al.
Publicado: (2022)

IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus
por: Russo, M.P., et al.
Publicado: (2022)

IDF21-0683 Social and emotional impact of the COVID-19 pandemic in people with Type 1 Diabetes
por: Rodriguez Montalvan, B.F., et al.
Publicado: (2022)

IDF21-0636 Effects of COVID-19 lockdown on lifestyle changes and medical challenges in patients with type 1 diabetes in south India
por: Guha Pradeepa, R.P., et al.
Publicado: (2022)

P02.94. Acupuncture to decrease disparities in outcomes of pain treatment (ADDOPT): preliminary outcomes
por: McKee, D, et al.
Publicado: (2012)

IDF21-0370 New forms of diabetic education during the COVID-19 pandemic
por: Bukovská, A.
Publicado: (2022)

IDF21-0331 Diabetes care to Palestine Refugees during COVID 19 pandemic
por: Shahin, Y.
Publicado: (2022)

IDF21-0533 Diabetes Mellitus in hospitalized COVID-19 patients – a retrospective cohort study
por: Çerma, A., et al.
Publicado: (2022)

IDF21-0110 The role of source hypoglycemic therapy and associated diseases in patients with type 2 diabetes mellitus and COVID-19
por: Markova, T.N., et al.
Publicado: (2022)

IDF21-0422 Two Anniversaries, Two Pandemics, Two Histories
por: Dapice, A.
Publicado: (2022)

IDF21-0498 Innovative ways to continue serving People with Type 1 Diabetes during Covid 19 pandemic
por: Abi Saad, M., et al.
Publicado: (2022)

IDF21-0340 Challenges Faced by Patients in Diabetes Care and Management in the Philippines During the COVID-19 Pandemic
por: Quinto, C.J., et al.
Publicado: (2022)

IDF21-0452 Virtual Diabetes Education Program for Children and Adolescents with Diabetes in Response to COVID-19 Pandemic
por: Alromaihi, D., et al.
Publicado: (2022)

IDF21-0450 Effect of COVID-19 lockdown and Ramadan fasting on glucose control in patients with diabetes: a glucose monitoring study
por: Helal, R., et al.
Publicado: (2022)

IDF21-0175 Experiences of delivering virtual education workshops for children with type 1 diabetes during the Covid-19 pandemic
por: Chan, P.L.C., et al.
Publicado: (2022)

IDF21-0090 Structure of mortality among patients with diabetes mellitus in the republic of Uzbekistan during COVID-19 pandemia
por: Tojieva, I., et al.
Publicado: (2022)

IDF21-0288 Virtually Sugar Free: Overcoming Challenges of Managing Gestational Diabetes (GDM) during a Pandemic
por: Khurana, R., et al.
Publicado: (2022)

IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection
por: Veríssimo, D., et al.
Publicado: (2022)

IDF21-0616 Observational study on covid 19 and type 1 diabetes in the Chronic Care Center Lebanon
por: Maalouf Nawfal, P., et al.
Publicado: (2022)

IDF21-0551 The Lockdown Effect, A1C and Diabetes (LEAD) control audit/study: East London single centre experience
por: Mlawa, G., et al.
Publicado: (2022)

Bariatric surgery: an IDF statement for obese Type 2 diabetes
por: Dixon, J B, et al.
Publicado: (2011)

IDF21-0373 Online education for parents of children and adolescents with newly diagnosed type 1 diabetes during COVID-19 pandemic
por: Kurganovich, A., et al.
Publicado: (2022)

IDF2022-0354 The impact of COVID-19 lockdown on the changes in glycated hemoglobin in patients with type 2 diabetic in Taiwan
por: Cheng, Y.C.
Publicado: (2023)

IDF21-0564 The Use of a Digital Self-Care Platform in The Control of Diabetes in People With Diabetes During the COVID-19 Pandemic
por: Jacobs, M., et al.
Publicado: (2022)

IDF21-0496 Action Taken in the Kingdom of Bahrain for People with Diabetes (Preparedness and Response)
por: Al Hajeri, M.E.
Publicado: (2022)

IDF21-0690 Diabetics hospitalized for covid infection under corticosteroid therapy, what is the particularity?
por: Yousra, L., et al.
Publicado: (2022)

IDF21-0611 The COVID-19 pandemic and Type 1 Diabetes (T1D): effect of the second wave on newly diagnosed children with T1D
por: Othman, F., et al.
Publicado: (2022)

IDF21-0593 COVID-19 hospitalizations and cardio-cerebrovascular complications at three months in people with diabetes
por: Iommi, M., et al.
Publicado: (2022)

IDF21-0445 Telehealth utilization in Diabetes Centre during COVID Pandemic in South-Western Sydney: An evolving model of care
por: Manoharan, M., et al.
Publicado: (2022)

IDF21-0390 Diabetes related hospital presentations to South-Western Sydney during COVID Pandemic: A retrospective analysis
por: Namboodiri, D., et al.
Publicado: (2022)

Effects of COVID-19 pandemic lockdown on the metabolic control of type 2 diabetes mellitus in patients
por: Eren, Mehmet Ali, et al.
Publicado: (2023)

IDF2022-0928 Impact of the COVID-19 Pandemic on Type 2 Diabetes Incidence in Canada: Will the Pandemic shift the Diabetes Trajectory?
por: Fazli, G., et al.
Publicado: (2023)

IDF21-0678 Telemedicine Use and Selfmanagement Behaviors of Persons with Type 2 DM in Luzon Philippines during the COVID-19 Pandemic
por: Abaigar Jr., M., et al.
Publicado: (2022)

IDF21-0532 Hyponatremia severity affects patient outcome in COVID-19 infection
por: Bogdanovic, J., et al.
Publicado: (2022)

IDF21-0567 Analysis of mortality and cardio-metabolic comorbidities in Covid-19 patients from Eastern European region
por: Popescu, I., et al.
Publicado: (2022)

Prevalence of Metabolic Syndrome in Type 2 Diabetes Mellitus Using NCEP-ATPIII, IDF and WHO Definition and Its Agreement in Gwalior Chambal Region of Central India
por: Yadav, Dhananjay, et al.
Publicado: (2013)

A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions
por: Herath, H. M. M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jtb3sob9mlj63uu730fol3ge55